[1] [2] As of 20242025, retatrutide remains under clinical investigation and has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, nor by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for routine clinical use
Multiple experimental models reported improved collagen organization, enhanced tensile strength, and pro-angiogenic signaling following injury
Purity: Refer to batch-specific Certificate of Analysis (COA)
That said, functional medicine thrives on looking at early evidence, asking good questions, and integrating therapies when benefits may outweigh risks
(PubMed) Bell KM, Plon L, Bunney WE, Jr., Potkin SG